Concepedia

Yaling Hu

YH

Statistics

Publications

21

Citations

5K

H-Index

16

Active since

2018

Affiliations

Sinovac Biotech(Current)

National Institutes for Food and Drug Control

Chinese Academy of Sciences

Chinese Academy of Medical Sciences & Peking Union Medical College

Institute of Biophysics

Yaling Hu is an author at Sinovac Biotech specializing in infectious diseases, immunology, and veterinary medicine.

ORCID

Publications per year

2018–2024

21

Publications

21

Development of an inactivated vaccine candidate for SARS-CoV-2

Qiang Gao, Linlin Bao, Haiyan Mao et al. · Science · 2020 · 1.5K citations · Full text

, , +15

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang, Gang Zeng, Hongxing Pan et al. · The Lancet Infectious Diseases · 2020 · 1.5K citations · Full text

, , +17

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Zhiwei Wu, Yaling Hu, Miao Xu et al. · The Lancet Infectious Diseases · 2021 · 575 citations · Full text

, , +17

Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent Patients

Xiaoli Wang, Xianghua Guo, Qianqian Xin et al. · Clinical Infectious Diseases · 2020 · 325 citations · Full text

, , +13

Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants

Kang Wang, Zijing Jia, Linilin Bao et al. · Nature · 2022 · 195 citations · Full text

, , +17

1–5 of 21